Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1965 Jul;44(7):1187–1199. doi: 10.1172/JCI105225

Oxidative Hemolysis and Erythrocyte Metabolism in Hereditary Acatalasia*

Harry S Jacob 1,, Sidney H Ingbar 1, James H Jandl 1
PMCID: PMC292593  PMID: 14328395

Full text

PDF
1187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AEBI H., HEINIGER J. P., BUETLER R., HAESSIG A. Two cases of acatalasia in Switzerland. Experientia. 1961 Oct 15;17:466–466. doi: 10.1007/BF02158293. [DOI] [PubMed] [Google Scholar]
  2. AEBI H., JEUNET F., RICHTERICH R., SUTER H., BUTLER R., FREI J., MARTI H. R. Observations in two Swiss families with acatalasia. Enzymol Biol Clin (Basel) 1962;2:1–22. doi: 10.1159/000458069. [DOI] [PubMed] [Google Scholar]
  3. ALLEN D. W., JANDL J. H. Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols in oxidant drug action. J Clin Invest. 1961 Mar;40:454–475. doi: 10.1172/JCI104273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BEAVEN G. H., WHITE J. C. Oxidation of phenylhydrazines in the presence of oxyhaemoglobin and the origin of Heinz bodies in erythrocytes. Nature. 1954 Feb 27;173(4400):389–391. doi: 10.1038/173389b0. [DOI] [PubMed] [Google Scholar]
  5. BEERS R. F., Jr, SIZER I. W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952 Mar;195(1):133–140. [PubMed] [Google Scholar]
  6. BEUTLER E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957 Jan;49(1):84–95. [PubMed] [Google Scholar]
  7. COHEN G., HOCHSTEIN P. GLUTATHIONE PEROXIDASE: THE PRIMARY AGENT FOR THE ELIMINATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES. Biochemistry. 1963 Nov-Dec;2:1420–1428. doi: 10.1021/bi00906a038. [DOI] [PubMed] [Google Scholar]
  8. COHEN G., HOCHSTEIN P. Glucose-6-phosphate dehydrogenase and detoxification of hydrogen peroxide in human erythrocytes. Science. 1961 Dec 1;134(3492):1756–1757. doi: 10.1126/science.134.3492.1756. [DOI] [PubMed] [Google Scholar]
  9. GRUNERT R. R., PHILLIPS P. H. A modification of the nitroprusside method of analysis for glutathione. Arch Biochem. 1951 Feb;30(2):217–225. [PubMed] [Google Scholar]
  10. HARLEY J. D., MAUER A. M. Studies on the formation of Heinz bodies. II. The nature and significance of Heinz bodies. Blood. 1961 Apr;17:418–433. [PubMed] [Google Scholar]
  11. HILL A. S., Jr, HAUT A., CARTWRIGHT G. E., WINTROBE M. M. THE ROLE OF NONHEMOGLOBIN PROTEINS AND REDUCED GLUTATHIONE IN THE PROTECTION OF HEMOGLOBIN FROM OXIDATION IN VITRO. J Clin Invest. 1964 Jan;43:17–26. doi: 10.1172/JCI104889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HUGGETT A. S., NIXON D. A. Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet. 1957 Aug 24;273(6991):368–370. doi: 10.1016/s0140-6736(57)92595-3. [DOI] [PubMed] [Google Scholar]
  13. JACOB H. S., JANDL J. H. Effects of sulfhydryl inhibition on red blood cells. I. Mechanism of hemolysis. J Clin Invest. 1962 Apr;41:779–792. doi: 10.1172/JCI104536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. JACOB H. S., JANDL J. H. Effects of sulfhydryl inhibition on red blood cells. II. Studies in vivo. J Clin Invest. 1962 Jul;41:1514–1523. doi: 10.1172/JCI104607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. JACOB H. S., JANDL J. H. INCREASED CELL MEMBRANE PERMEABILITY IN THE PATHOGENESIS OF HEREDITARY SPHEROCYTOSIS. J Clin Invest. 1964 Aug;43:1704–1720. doi: 10.1172/JCI105046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. JANDL J. H., ENGLE L. K., ALLEN D. W. Oxidative hemolysis and precipitation of hemoglobin. I. Heinz body anemias as an acceleration of red cell aging. J Clin Invest. 1960 Dec;39:1818–1836. doi: 10.1172/JCI104206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. JANDL J. H., GREENBERG M. S., YONEMOTO R. H., CASTLE W. B. Clinical determination of the sites of red cell sequestration in hemolytic anemias. J Clin Invest. 1956 Aug;35(8):842–867. doi: 10.1172/JCI103338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keilin D., Hartree E. F. Properties of catalase. Catalysis of coupled oxidation of alcohols. Biochem J. 1945;39(4):293–301. [PMC free article] [PubMed] [Google Scholar]
  19. MILLS G. C. Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem. 1957 Nov;229(1):189–197. [PubMed] [Google Scholar]
  20. MILLS G. C., RANDALL H. P. Hemoglobin catabolism. II. The protection of hemoglobin from oxidative breakdown in the intact erythrocyte. J Biol Chem. 1958 Jun;232(2):589–598. [PubMed] [Google Scholar]
  21. SZEINBERG A., MARKS P. A. Substances stimulating glucose catabolism by the oxidative reactions of the pentose phosphate pathway in human erythrocytes. J Clin Invest. 1961 Jun;40:914–924. doi: 10.1172/JCI104330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TAKAHARA S. Progressive oral gangrene due to acatalasemia (colored motion picture). Laryngoscope. 1954 Aug;64(8):685–688. doi: 10.1288/00005537-195408000-00004. [DOI] [PubMed] [Google Scholar]
  23. TAKAHARA S. Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases. Lancet. 1952 Dec 6;2(6745):1101–1104. doi: 10.1016/s0140-6736(52)90939-2. [DOI] [PubMed] [Google Scholar]
  24. TARLOV A. R., BREWER G. J., CARSON P. E., ALVING A. S. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med. 1962 Feb;109:209–234. doi: 10.1001/archinte.1962.03620140081013. [DOI] [PubMed] [Google Scholar]
  25. TARLOV A. R., KELLERMEYER R. W. The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes. J Lab Clin Med. 1961 Aug;58:204–216. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES